申请人:Santen Pharmaceutical Co., Ltd.
公开号:US04547513A1
公开(公告)日:1985-10-15
This invention relates to novel benzothiazoline derivatives of the formula [I] and salts thereof, ##STR1## wherein R.sup.1 is formyl or lower alkanoyl; R.sup.2 is hydrogen, lower alkyl, lower alkoxy or nitro; R.sup.3 is hydrogen, lower alkyl, lower alkoxy or halogen; A is lower alkylene; B is --CO--(CH.sub.2).sub.m -- or --CH(OH)--; m is 0 or 1; and when m is 0, R.sup.3 is not hydrogen. The compounds of this invention are useful for treatment of cardiovascular diseases.
本发明涉及一种新型苯并噻唑衍生物及其盐,其化学式为[I],其中R1为甲酰基或低级脂肪酰基;R2为氢、低级烷基、低级烷氧基或硝基;R3为氢、低级烷基、低级烷氧基或卤素;A为低级烷基;B为--CO--(CH2)m--或--CH(OH)--;m为0或1;当m为0时,R3不为氢。本发明的化合物对治疗心血管疾病有用。